DarioHealth
Personalized, pocket-sized, all-in-one glucose meter coupled with a robust real time mobile app to manage diabetes quickly, efficiently and accurately.
Launch date
Employees
Market cap
€25.9m
Enterprise valuation
€33m (Public information from Sep 2024)
Share price
$1 DRIO
New York City New York (HQ), Hof HaCarmel Regional Council Haifa District (founding location)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 7.6m | 20.5m | 27.7m | 20.4m | 27.2m | 37.0m | 50.3m |
% growth | - | 171 % | 35 % | (26 %) | 34 % | 36 % | 36 % |
EBITDA | (30.2m) | (73.0m) | (52.4m) | (50.0m) | (30.1m) | (11.7m) | (<1m) |
% EBITDA margin | (398 %) | (356 %) | (189 %) | (246 %) | (111 %) | (32 %) | (2 %) |
Profit | (29.4m) | (76.8m) | (62.2m) | (59.4m) | (43.9m) | (34.6m) | (34.7m) |
% profit margin | (389 %) | (374 %) | (225 %) | (292 %) | (161 %) | (94 %) | (69 %) |
EV / revenue | 15.3x | 10.5x | 4.0x | 2.3x | 0.9x | 0.7x | 0.5x |
EV / EBITDA | -3.9x | -3.0x | -2.1x | -0.9x | -0.8x | -2.1x | -31.9x |
R&D budget | 4.4m | 17.2m | 19.6m | 20.2m | - | - | - |
R&D % of revenue | 59 % | 84 % | 71 % | 99 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $800k | Seed | |
N/A | $1.2m | Early VC | |
N/A | $10.0m | Series A | |
N/A | N/A | IPO | |
N/A | $4.2m | Post IPO Equity | |
N/A | N/A | Post IPO Equity | |
N/A | $1.6m | Post IPO Equity | |
N/A | $461k | Post IPO Equity | |
N/A | $790k | Post IPO Equity | |
N/A | $400k | Post IPO Equity | |
* | €4.6m | Post IPO Equity | |
$2.5m | Post IPO Equity | ||
* | N/A | $10.3m | Private Placement VC |
N/A | $21.3m | Post IPO Equity | |
N/A | $28.6m | Post IPO Equity | |
$70.0m | Private Placement VC | ||
* | N/A | $14.3m | Post IPO Convertible |
* | $30.0m | Post IPO Debt | |
Total Funding | €83.9m |
Related Content
Recent News about DarioHealth
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by DarioHealth
EditACQUISITION by DarioHealth Feb 2024
ACQUISITION by DarioHealth Jan 2021
ACQUISITION by DarioHealth Jan 2022
ACQUISITION by DarioHealth May 2021